CNS Drugs

Bacterial Meningitis: Current Controversies in Approaches to Treatment
pp. 909-919(11)
Authors: Williams A.J.; Nadel S.

Magnesium for Neuroprotection in Ischaemic Stroke: Rationale for Use and Evidence of Effectiveness
pp. 921-930(10)
Author: Muir K.W.

Diagnosis and Treatment of Nonconvulsive Status Epilepticus
pp. 931-939(9)
Author: Walker M.C.

Third-Generation Antidepressants: Do They Offer Advantages Over the SSRIs?
pp. 941-954(14)
Authors: Olver J.S.; Burrows G.D.; Norman T.R.

Future Prospects for the Drug Treatment of Epilepsy
pp. 955-968(14)
Authors: Nicolson A.; Leach J.P.

Frovatriptan
pp. 969-976(8)
Authors: Easthope S.E.; Goa K.L.

Frovatriptan: A Viewpoint by Dr Hans Christoph Diener
pp. 977-978(2)
Author: Diener H.C.

Frovatriptan: A Viewpoint by Dr NT Mathew
pp. 977-978(2)
Author: Mathew N.T.